click below
click below
Normal Size Small Size show me how
ATI SKILLS Module
Medication Administration Skills (Exam 2)
| Question | Answer |
|---|---|
| AC | Before meals |
| PC | After meals |
| PRN | As needed |
| daily | Every day |
| stat | Give immediately |
| PO | By mouth |
| SL | Sublingually |
| ID | Intradermal |
| IM | Intramuscular |
| IV | Intravenous |
| top | Topical |
| p | After |
| c | With |
| s | Without |
| liq | Liquid |
| susp | Suspension |
| NPO | Nothing by mouth |
| Which of the following describes a medication's generic name? | It is the same as its nonproprietary name. |
| The routes of administration are usually divided into two categories: | parenteral and nonparenteral |
| . Parenteral includes | intramuscular, subcutaneous, intradermal, IV, intrathecal, and epidural routes. |
| Nonparenteral encompasses | oral, sublingual, topical, transdermal, ophthalmic, otic, nasal, rectal, and vaginal routes. |
| Parenteral routes offer | the most direct and reliable method of administering medications while also providing the most rapid absorption. |
| Genetic-based differences in medication metabolism | variation is due to genetic alterations in specific medication-metabolizing enzymes and becomes apparent in an individual’s response to the medication. |
| Medication distribution relies on | blood flow to the intended sites of action, biological barriers, and protein-binding capacity. |
| Metabolism is primarily the function of | the liver, although the kidneys, lungs, intestines, and blood also play a role. |
| Medications can be excreted through the | kidneys, liver, bowel, lungs, or exocrine glands, including the skin and mammary glands. |
| Sites for the excretion of metabolized medications are determined by | the chemical composition of the medication |
| What determine the rate of excretion and have the potential for prolonging the medication’s actions | client’s renal and hepatic function, bowel motility, ventilatory ability, and skin integrity |
| Synergistic effects | develop when the combination of two or more medications or substances results in a greater effect than that of separate administration would. |
| Medications are measured using three different systems: | the metric system, the apothecary system, and the household system |
| Units of Measure: c | Cup |
| Units of Measure: cc | Cubic centimeter |
| Units of Measure: cm | Centimeter |
| Units of Measure: fl | Fluid |
| Units of Measure: g or gm | Gram |
| Units of Measure: gtt | Drop |
| Units of Measure: in | Inch |
| Units of Measure: kg | Kilogram |
| Units of Measure: L | Liter |
| Units of Measure: lb or | Pound |
| Units of Measure: m | Meter |
| Units of Measure: mcg | Microgram |
| Units of Measure: mEq | Milliequivalent |
| Units of Measure: mg | Milligram |
| Units of Measure: mL | Milliliter |
| Units of Measure: mm | Millimeter |
| Units of Measure: oz | Ounce |
| Units of Measure: tbsp | Tablespoon |
| Units of Measure: tsp | Teaspoon |
| implementing the rights of medication administration | right medication, right dose, right route, right time, right client, right documentation, client’s right to receive education, right reason or indication based on assessment of client, right evaluation, and the right of client to refuse the medication. |
| Which of the following actions demonstrates correct use of one of the rights of medication administration? | Administering a client's medication by the route the provider has prescribed |
| acromial process | Lateral extension of the spine of the scapula, projecting over the shoulder joint and forming the highest point of the shoulder. |
| adverse effect | Undesirable and potentially dangerous responses to a medication. Adverse effects may be inadvertent or predictable. Some are immediate, whereas others take weeks or months to develop. |
| ampule | Small, sealed, single-use glass or plastic container for holding sterile medications and solutions. |
| antimicrobial agent | Agents that destroy or prevent the multiplication and growth of microbes and pathogens. |
| buccal administration | Route of medication administration in which medication is placed inside the client’s mouth next to the cheek or the gum and allowed to dissolve. |
| canthus | Angle formed where the upper and lower eyelids meet. This can be the inner or medial canthus, or the outer or lateral canthus. |
| capsule | Form of a specific dosage of medication that is contained within a gelatin shell. The gelatin shell dissolves in the stomach or intestine, and the medication is absorbed. |
| cerumen | Brownish or yellowish waxy secretions in the external ear canal produced by the ceruminous gland. |
| conjunctival sac | Space lined by the conjuntiva between the eyelid and the eye. |
| diluent | Substance, such as water, glycerin, or starch, added to another to reduce its potency or thin its consistency. |
| enteral administration | Delivery of fluids, food, medication or other substances through the gastrointestinal system. |
| filter needle | Needle with a filter that prevents small particles of medication, glass, or rubber from entering the barrel of the syringe and being injected into the client. |
| injection | Insertion of a substance into the body, container or space. |
| intradermal administration | Administration of medication, nutrients or other fluid via injection into the top layer of dermis. |
| intramuscular administration | Method of medication administration in which medications are injected directly into a large muscle (deltoid, vastus lateralis, ventrogluteal). |
| intravenous administration | Delivery of fluids, medications, blood and other substances within or into a vein. |
| lateral semi-prone recumbent position | Posture halfway between lateral and prone positions with the lower arm behind the client, the upper arm bent in front of the client, and both legs flexed in front of the client at the hip and knee, with the upper leg slightly more flexed. |
| medication administration record (MAR) | Document used to verify that a client's medications were or were not administered. It contains a client’s prescribed medications, dosage, route, administration times, and parameters for administration. |
| medication compatibility | When two or more medications can be combined without producing harmful effects or impairing the actions of any of the medications. |
| metered-dose inhaler (MDI) | Aerosol canister that releases a defined dose of medication for inhalation through the mouth |
| multidose | Form of packaging of a medication in which more than 1 dose is available. |
| nebulizer | Device that converts a liquid or a solid into a mist or vapor. |
| ophthalmic administration | Administration of a medication or other substance onto the surface of the eye. |
| otic administration | Administration of medication or other substance into the ear. |
| over-the-counter medication | Medication that is safe and effective for use by the general public without seeking treatment by a health professional |
| parenteral administration | Delivery of therapeutics by means other than through the gastrointestinal tract; often used to indicate the delivery of medications using the subcutaneous, intramuscular, or IV routes. |
| reconstitute | To restore a dried substance to a fluid form. |
| rectal administration | Administration of a medication or other substance into the rectum. |
| subcutaneous administration | Method of medication administration in which medications are injected into the tissue directly under the dermis. |
| suppository | Solid, dissolvable cone-shaped medication preparation inserted into the rectum, vagina, or urethra. |
| systemic effect | Effect that occurs in tissues distant from the administration site of a therapy. |
| tablet | Form of a specific dosage of medication that is compressed into a disk for ease of administration. |
| therapeutic effect | Expected action or change that is good or healing. |
| topical administration | Administration of medication, fluid or other substance to the exterior of the body, especially the skin or mucous membranes. |
| toxic effect | Effect or reaction from the ingestion, injection, inhalation of, or exposure to an excessive dose of a chemical agent. |
| transdermal patch administration | Delivery of medication through an adhesive patch placed on the skin that allows slow and steady absorption of the medication. |
| unit-dose packaging | Method of packaging medications in which individual doses are prepared and delivered in individually labeled packages. |
| vital signs | Reflection of the body's physiological function; includes temperature, blood pressure, respiratory rate, heart rate, oxygen saturation, and sometimes pain level. |
| wheal | Smooth, reddened or pale, slightly elevated area on the skin that is either induced via intradermal injection or is typical of allergic reactions. |
| Z-track method | Method of intramuscular injection in which the skin and subcutaneous tissue are displaced prior to insertion of the needle to prevent leakage via the injection site once the needle is removed. |
| needle-less (blunts) | Only for drawing up meds from vial |